Published online March 1, 2005
PEDIATRICS Vol. 115 No. 4 April 2005, pp. e504-e507 (doi:10.1542/peds.2004-1395)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nathan, A.
Right arrow Articles by Milovcich, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nathan, A.
Right arrow Articles by Milovcich, K.
Related Collections
Right arrow Blood

ELECTRONIC ARTICLE

Primary Erythromelalgia in a Child Responding to Intravenous Lidocaine and Oral Mexiletine Treatment

Aruna Nathan, MD, John B. Rose, MD, Jessica W. Guite, PhD, David Hehir, MD and Karen Milovcich, CRNP

From the Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, and Department of Anesthesiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Erythromelalgia is a rare, chronic, debilitating condition characterized by redness, warmth, and severe burning pain of the distal extremities. The feet are more commonly affected than the hands. Pain is precipitated by increases in temperature and by exercise. Patients often obtain relief by immersing the affected extremity in cold water. The pain is often refractory to treatment. For many patients, multiple pain medications have been useless in achieving complete relief of pain symptoms. Previous reports of erythromelalgia among adolescents indicated prolonged relief of pain with sodium nitroprusside infusions, epidural infusions of local anesthetics, or gabapentin treatment. We present a case of an 11-year-old, white, male child with primary erythromelalgia, whose initial symptoms started in his preschool years and whose childhood was marked by escalating episodes of pain with warmth and redness of his feet, precipitated especially by increases in temperature and by activity. All conventional pain management techniques had failed to relieve our patient of his symptoms, and he obtained some relief only by soaking his affected extremities in ice water. He had experienced minimal benefit from seeing a pain psychologist, who helped him develop techniques to cope with the pain. At the time of presentation, the patient's episodes of pain had increased to 15 to 20 per day, and there was evidence of chronic immersion injury to the skin of his feet. Before his most recent hospitalization, the pain had spread to involve his hands as well. The patient was overwhelmed with anxiety and could not participate in school or social activities at the time of admission. During his current hospitalization, he did show some therapeutic response to sodium nitroprusside infusion, which unfortunately had to be discontinued because of side effects and because his family desired to leave the ICU environment, which was stressful to the patient. He also had some response to lumbar epidural infusion of local anesthetics, which could not be continued because he found the motor blockade that accompanied his analgesia intolerable. However, intravenous lidocaine infusion, with subsequent transition to oral mexiletine therapy, proved very effective in reducing the frequency and severity of the pain episodes. The patient was discharged from the hospital with oral mexiletine therapy and has been monitored at the pain management clinic. He returned to and completed school, attended summer camp, and enjoys an active happy life. He walks without precipitating pain in his feet and sleeps 9 to 10 hours every night. He has needed to soak his feet on only 4 occasions in the 6 months since his discharge from the hospital. His quality of life has improved significantly. He has shown no evidence of liver toxicity, and his mexiletine levels have been stable.

Key Words: erythromelalgia • lidocaine • mexiletine

Accepted Nov 8, 2004.




This article has been cited by other articles:


Home page
 NeurologyHome page
C. R. Fertleman, C. D. Ferrie, J. Aicardi, N.A.F. Bednarek, O. Eeg-Olofsson, F. V. Elmslie, D. A. Griesemer, F. Goutieres, M. Kirkpatrick, I. N.O. Malmros, et al.
Paroxysmal extreme pain disorder (previously familial rectal pain syndrome)
Neurology, August 7, 2007; 69(6): 586 - 595.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. Paticoff, A. Valovska, S. S. Nedeljkovic, and A. L. Oaklander
Defining a Treatable Cause of Erythromelalgia: Acute Adolescent Autoimmune Small-Fiber Axonopathy
Anesth. Analg., February 1, 2007; 104(2): 438 - 441.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T. P. Harty, S. D. Dib-Hajj, L. Tyrrell, R. Blackman, F. M. Hisama, J. B. Rose, and S. G. Waxman
Nav1.7 Mutant A863P in Erythromelalgia: Effects of Altered Activation and Steady-State Inactivation on Excitability of Nociceptive Dorsal Root Ganglion Neurons
J. Neurosci., November 29, 2006; 26(48): 12566 - 12575.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J.-S. Choi, S. D. Dib-Hajj, and S. G. Waxman
Inherited erythermalgia: Limb pain from an S4 charge-neutral Na channelopathy
Neurology, November 14, 2006; 67(9): 1563 - 1567.
[Abstract] [Full Text] [PDF]